J&J hits main goal in early-stage trial for drug delivery system
Johnson & Johnson (JNJ) announced on Friday the achievement of a primary safety endpoint in a Phase 1 trial for a drug...
News / Analytics / Reviews
Johnson & Johnson (JNJ) announced on Friday the achievement of a primary safety endpoint in a Phase 1 trial for a drug...
Johnson & Johnson (JNJ) announced on Thursday that the U.S. Food and Drug Administration (FDA) approved its Tecnis...
Johnson & Johnson (JNJ) subsidiaries Actelion Pharmaceuticals and Janssen Research & Development have agreed to...
Six Democratic senators, including Senate Finance Committee Ranking Member Ron Wyden (D-Ore.), have sent letters to more...
The U.S. Food and Drug Administration on Thursday approved Johnson & Johnson's (JNJ) antibody therapy Tecvayli...
A bid by Kenvue (KVUE) to dismiss a lawsuit brought against it by Texas Attorney General Ken Paxton accusing the company of...
Johnson & Johnson (JNJ) has submitted a supplemental New Drug Application to the US FDA seeking approval of Imaavy...
New Jersey-based Johnson & Johnson (JNJ) defended its testing and marketing. "Litigation does not change data," a...
This week's dividend activity included increased payouts from Sherwin-Williams (SHW) and Analog Devices (ADI) as well as...
Johnson & Johnson (JNJ) is exploring a sale of its orthopedics business, DePuy Synthes, in a deal that could have a...